We’re about to close up the world headquarters of Terra Sigillata to head out and convene with the PharmFamily in points north for Easter (but, thankfully, not a Nor’easter.)
Before we do, I’d like to draw your attention to a short but astute editorial in The Chronicle of Higher Education by chemist Gina Stewart. Stewart launches her essay with a concise description of a dichotomy that’s giving all of us agita:
The STEM paradox: At a time when we have a national dialogue about the dearth of students pursuing these degrees, newly minted Ph.D.’s are having a harder time landing academic jobs.
She then talks about her career and what she considers to be the shortest postdoc on record (believe me, Gina, I know of many shorter) in the UNC-Chapel Hill laboratory of Joe DeSimone. There, the seeds were planted for entrepreurship and a fascination with the practical applications of carbon dioxide.
Years later, Stewart is now CEO of Arctic, Inc., a company that uses sustainable weed control methods by selectively freezing these nasty invasive threats to biodiversity – her company site is appropriately named frostkills.com.
Her experience is one example where one takes a different approach to a chemistry career than following in the traditional academic progression. The first commenter already admonished her for saying that she was pursuing an alternative career. Based on percentages, being a tenure-track faculty member is now the alternative.
It’s a great read so enjoy. I was also delighted to learn that she and her husband live just west of the Research Triangle and base their company in Clemmons, NC.
If you’re up on this lovely Saturday morning and looking for something fun and educational to pass the time, dial up wknc.org for the “Mystery Roach” radio show from 8 am until 10 am Eastern time.
There, I’ll be discussing the discovery of drugs from nature and the differences between herbal remedies and medicines.
The show, hosted by forestry and natural resources doctoral student Damian Maddalena, will be interspersed with psychedelic music from the 60s and 70s.
Maddalena is an experienced scientist-communicator whose show, named after a Frank Zappa song, celebrated five years last November. The Research Triangle’s independent weekly, INDY Week, recognized Maddalena last year as runner-up for both top radio show and radio host, a tremendous accomplishment for a science and music show in a highly-competitive media market.
Livestream at this wknc.org page
Well, leave it to the British to put together one of the most enjoyable exercises of the day, at least for those of us with even a few remaining molecules of Catholicism.
With apologies to my calculus teacher, Sister Agnes Mary of St. Mary’s High School in Rutherford, New Jersey, I present to you the UK Guardian‘s Pontifficator.
Choose your own pope – with our interactive Pontifficator
This week, 115 cardinals will be secreted in the Sistine Chapel to select one of their number as the next head of the Catholic church. You can’t get in to see them but you can use our interactive to explore their views on issues from contraception to relations with other faiths, peruse their CVs, and choose the man you think is best qualified for the job. Tap the pictures to read more about the candidates. There’s a note on how we categorised them here
Finding a pontiff who meets all of one’s criteria is tougher than finding an apartment in New York City. But my selection ended up being Archbishop of Tegucigalpa (Honduras), Óscar Andrés Rodríguez Maradiaga.
The clincher? Of the 10 academic candidates, he’s taught chemistry and physics.
Of course, I’m not keen on his rating for handling the sex abuse scandals in the church and, shockingly, his agreement with the current pope that condoms will not prevent the global HIV/AIDS crisis.
Umm, I don’t know what kind of chemistry and physics he taught.
So if I still were a churchgoer, I’d have to pass on Rodríguez Maradiaga. Italy’s “tech-savvy” Gianfranco Ravasi is notable for having hosted the 2009 Vatican conference on evolution. But something tells me that this time won’t break the latest string of non-Italian popes.
For those of you interested in the outcome of the papal conclave, who are your favorites?
I’m hoping it’s someone from South America or Africa.
I just received two hits to my PhD defense post using this search phrase.
To the reader: If you are in such dire straits of stress before your defense, please call 911 immediately or get yourself to your local emergency room. The specter of the dissertation defense can amplify self-doubt and if you are considering suicide, you and your family and friends would be better served by you postponing your defense and checking into a hospital for a couple of weeks.
If I can be of any help, please Gmail me at abelpharmboy call me at 919.564.9564. But first call 911.
Free, as always, you can sign up to participate at this link.
McKenna’s book, SUPERBUG: The Fatal Menace of MRSA, is a thorough and accessible investigation of the reemergence of lethal bacterial infections while new drug development lags.
The book, now in paperback, received the 2011 Science in Society Award from the the National Association of Science Writers.
McKenna had spent much of her career at the Atlanta Journal-Constitution as the only U.S. reporter assigned full time to the Centers for Disease Control and Prevention. In fact, her first book, Beating Back the Devil, detailed her experiences with CDC’s Epidemic Investigation Service (EIS), the team dispatched anywhere in the world that’s experiencing an unusual infectious disease event.
From her book’s website:
I was following a group of disease detectives from the Centers for Disease Control and Prevention, the CDC, through an investigation of bizarre skin infections in Los Angeles. The CDC wanted to know where men were picking them up. I wanted to know something more fundamental: How could a minor problem — something that the victims all described as looking like a tiny spider bite — blow up into massive infections that ate away at skin and muscle, put people into the hospital for weeks and drained their health and their bank accounts? Where had it come from? And if it could do that, what else was it capable of?
Maryn’s one of the best science writers in the world in terms of mastering her subject and making it widely accessible.
Of course, her webinar will be of interest to anyone concerned about the proliferation of drug-resistant infectious diseases and how to design drugs to stay a step ahead of evolution.
But she’s also a great model to emulate for anyone trying to make their scientific work more approachable to non-experts. You might even learn a thing or two about telling a gripping story.
And, thanks to your American Chemical Society, dialing into the webinar is FREE. Go here to register.
You don’t even need to be an ACS member!
You can thank me later.
By the way, read it if you haven’t — it’s open-access on C&EN right now and remains the most-read (last 7 days), most-commented (last 30 days), and most-shared (last 30 days) article since it appeared. Lauren did a terrific job of sifting through decades of information on the physiological effects of caffeine to make sense out of the true health hazards of caffeine consumption at “normal” and excessive doses.
Caffeine, a natural alkaloid found predominantly in coffee beans, is 1,3,7-trimethylxanthine (not IUPAC, but you get it). In the body, the hepatic cytochrome P450 CYP1A2 catalyzes the N-demethylation of caffeine to theophylline, theobromine, and paraxanthine.
Of note, theobromine and theophylline also occur in nature. Theobromine is found in cacao beans. Because chocolate is heavenly, it was given the Greek name for “food of the gods”: theos – god; broma – food.
Correct, theobromine contains no bromine. Had it contained bromine, the name might have been the same but would have been derived from the Greek bromos, or “stench” – “stench of the gods,” which, clearly, it is not.
Theophylline also occurs naturally and had been extensively used as a bronchodilator for folks with asthma. Primatene tablets used to contain theophylline but today are ephedrine. Again, theophylline has the godly theo- prefix while the -phylline suffix indicated that it comes from leaves.
And apologies to paraxanthine. It’s known historically for having first been isolated from urine in 1883. Not until the 1980s was it shown to occur in some plants. In any case, the biosynthesis of the di- and tri-methylxanthines originate with xanthosine from purine metabolism.
So to my question. . .
Because caffeine is so widely worshiped, why is it not known as theoanaleptine? The Greek analeptikos means stimulant and the English term analeptic is defined as a stimulant drug.
So, why not?
My best guess is because caffeine was described in the literature prior to theophylline and theobromine. From M.J. Arnaud’s chapter in Caffeine (Springer, 1984):
The isolation of caffeine from green coffee beans was described in Germany in 1820 by Runge and confirmed the same year by von Giese. In France, Robiquet in 1823 and then Pelletier in 1826 independently discovered a white and volatile crystalline substance. The name “cofeina” appeared in 1823 in the “Dictionaire des termes de medécine” and the word “caffein” or “coffein” was used by Fechner in 1826.
Arnaud goes on to say that theobromine was discovered in cocoa beans in 1842 and theophylline in tea leaves in 1888.
So, caffeine had about a two-decade headstart in being named for its presence in coffee before related methylxanthines took on their divine monikers.
Sure, sure, caffeine is a well-recognized name that derives predictably from its source. But let’s live a little. Wouldn’t you rather be drinking the stimulant of the gods?
If you’re as excited about this as I am, you may purchase theoanaleptine coffee mugs here. They’ll set you apart from ever Tom, Dick, and Harriet who think they’re clever with their caffeine coffee mugs.
And even with accepting the new colloquial name of theoanaleptine, our friend Scicurious can still keep her tattoo unchanged.
This week, the Research Triangle area is hosting ScienceOnline2013, an international science communications unconference that draws Pulitzer Prize-winning science writers, big media, graduate students, new media, science teachers, old media – pretty much anyone who’s involved in communicating science to diverse audiences via digital media.
The gathering began as the North Carolina Science Blogging Conference in 2007 (and probably before that) and has grown to be a highly-competitive ticket for 450 attendees. So popular are the conversations there that “watch parties” are being held in cities worldwide – London, Paris, Adelaide, Denver, Dublin, Belgrade, and others.
But the conversation can also be easily accessed via Twitter by following the hashtag #scio13.
I’d love to draw the C&EN and CENtral Science crowd to a superb session that will be held Saturday, 2 February, with our own Dr. Carmen Drahl and chemistry professor/former ACS intern Dr. Rubidium on chemophobia: the public aversion to anything that carries the label of “chemical.”
Here’s the description from the unconference wiki for tomorrow’s 10:30 am EST session:
Description: In today’s advertising and pop culture, words like “chemical”, “synthetic” and “artificial” are synonyms for harmful, toxic and carcinogenic, while words like “natural” and “organic” imply a product is wholesome and good for the environment. This widespread misconception colors public perceptions of chemistry and its role in the modern world. Chemophobia may not be as direct a threat to our future as, say, climate change denialism or the Israeli-Palestinian crisis, but it clouds public understanding of real and very important issues we face (e.g., how to boost agricultural productivity) and plays into the hands of quacks and cranks. How can bloggers and the media effectively combat chemophobia? How much chemistry does the public need to know to be well-informed and make good decisions, and what’s the most effective avenue for disseminating that kind of information? Proposed session hashtag: #chemophobia
Over the past year, several folks in the blogosphere and chemistry education realm have been providing folks like Carmen, DrR, and author Deborah Blum with examples of chemicals being portrayed as “bad.”
Yet, each of us are a glorious bag of chemicals (thankfully).
Where does the negative perception arise and how can we in chemistry-related fields better communicate with the public?
Carmen and DrRubidium have asked us to follow the #chemophobia hashtag on Saturday 10:30-11:30 am EST.
As I alluded to earlier on this index page, I was fortunate to score the cover story the January 9th issue of the Research Triangle’s alternative weekly paper, INDY Week. Therein, I told the story of Robert J. Lefkowitz, MD, the biochemist and cardiologist who shared the Nobel Prize in Chemistry 2012 with his former cardiology fellow, Brian K. Kobilka, MD, of Stanford University.
In this first edition of pixels that didn’t make it to the final article, I want to follow on the moments after I took this photo after interviewing Bob for the article. He was kind enough to bring in his original Nobel medal and diploma for me to see and photograph (he’s currently having a replica made of the medal so that he doesn’t have to carry around the real one.).
I was fortunate to be able to tell the story of Duke University biochemist and cardiologist Dr. Robert J. Lefkowitz in the 9 January 2013 issue of the Research Triangle’s award-winning alt-weekly, INDY Week.
Even with editor Lisa Sorg graciously offering 3,000+ words for the story on one of the 2012 Nobel laureates in chemistry, some terrific bits of my interviews with Bob and major players in his story didn’t make it into the final version.
Over the next few days, I’ll post some of these gems. This page will index the running list of those posts.
The Nobel’s Great, But Take a Look at This! – Lefkowitz reveals where Duke men’s basketball sits in his list of priorities
Harkening back to my Polish roots, I hereby declare Bob Dylan’s remake of Mitch Miller’s “Must Be Santa” (1960) as our official Christmas song. Written by Bill Fredericks and Hal Moore, Dylan’s take derives from the polka adaptation Brave Combo of Denton, Texas (here’s their version for comparison).
With your help, it might hit 2 million views by Christmas Day. As of the time of this post, it was at 1,997,052.
Best wishes to all of our readers for health and happiness no matter what holiday you celebrate this season!
From The CENtral Science Blogs
- Mar 10th, 2014By Alex Tullo
- Mar 6th, 2014By Bethany Halford
- Mar 10th, 2014By Rachel Pepling
- Mar 7th, 2014By Melody Bomgardner
- Jan 25th, 2014By David Kroll
- Feb 28th, 2014By Sarah Everts
- Feb 27th, 2014By Jyllian Kemsley
- Jan 26th, 2014By Rick Mullin